At the time of writing, Aptose Biosciences Inc [APTO] stock is trading at $1.66, up 10.67%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The APTO shares have gain 5.73% over the last week, with a monthly amount drifted -10.27%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 26, March 2024, Aptose Reports Results for the Fourth Quarter and Full Year 2023. In a post published today on Yahoo Finance, Tuspetinib to Advance to TUS+VEN+HMA Triplet Therapy Pilot Study in 1L AML.
From an analyst’s perspective:
Aptose Biosciences Inc [NASDAQ: APTO] stock has seen the most recent analyst activity on October 19, 2020, when Cantor Fitzgerald initiated its Overweight rating and assigned the stock a price target of $10. Previously, Alliance Global Partners started tracking the stock with Buy rating on September 22, 2020, and set its price target to $12. On February 20, 2020, Maxim Group initiated with a Buy rating and assigned a price target of $16 on the stock. H.C. Wainwright reiterated its Buy rating and increased its price target to $9 on February 06, 2020. Piper Sandler initiated its recommendation with a Overweight and recommended $10 as its price target on January 09, 2020. RBC Capital Mkts started tracking with a Outperform rating for this stock on March 01, 2019, and assigned it a price target of $6. In a note dated November 16, 2018, B. Riley FBR initiated an Buy rating and provided a target price of $5 on this stock.
For the past year, the stock price of Aptose Biosciences Inc fluctuated between $1.36 and $10.12. Aptose Biosciences Inc [NASDAQ: APTO] shares were valued at $1.66 at the most recent close of the market.
Analyzing the APTO fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -2.35, Equity is 0.47 and Total Capital is -5.91. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.14.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.5400 points at the first support level, and at 1.4200 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.7400, and for the 2nd resistance point, it is at 1.8200.
Aptose Biosciences Inc [APTO] reported earnings per share of -$1.44 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$1.59/share, meaning a difference of $0.15 and a surprise factor of 9.40%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were -$1.76 per share as compared to estimates of -$2.05 per share, a difference of $0.29 representing a surprise of 14.10%.
Ratios To Look Out For
It is important to note that Aptose Biosciences Inc [NASDAQ:APTO] has a current ratio of 0.78. Further, the Quick Ratio stands at 0.78, while the Cash Ratio is 1.27.
Transactions by insiders
Recent insider trading involved Seizinger Bernd R., Director, that happened on Sep 22 ’23 when 17000.0 shares were purchased.
